BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 26,011,000
- Total 13F shares
- 3,723,565
- Share change
- -971,621
- Total reported value
- $34,207,000
- Price per share
- $9.20
- Number of holders
- 19
- Value change
- -$9,901,055
- Number of buys
- 10
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075P105:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.4%
|
1,666,666
|
$17,067,000 | — | 31 Mar 2018 | |
| Artemis Investment Management LLP |
13F
|
Company |
4.7%
|
1,210,435
|
$12,237,000 | — | 31 Mar 2018 | |
| BARCLAYS PLC |
13F
|
Company |
2.4%
|
618,249
|
$6,331,000 | — | 31 Mar 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
1.3%
|
328,300
|
$3,362,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
295,000
|
$3,020,000 | — | 31 Mar 2018 | |
| ASCEND CAPITAL, LLC |
13F
|
Company |
0.77%
|
200,497
|
$2,053,000 | — | 31 Mar 2018 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.35%
|
90,000
|
$922,000 | — | 31 Mar 2018 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.25%
|
65,412
|
$670,000 | — | 31 Mar 2018 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.23%
|
59,451
|
$609,000 | — | 31 Mar 2018 | |
| DC Investments Management, LLC |
13F
|
Company |
0.14%
|
35,556
|
$364,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
30,889
|
$316,000 | — | 31 Mar 2018 | |
| Prudence Asset Management Ltd |
13F
|
Company |
0.12%
|
30,000
|
$307,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
27,880
|
$285,000 | — | 31 Mar 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.04%
|
11,323
|
$116,000 | — | 31 Mar 2018 | |
| Laurion Capital Management LP |
13F
|
Company |
0.04%
|
10,000
|
$102,000 | — | 31 Mar 2018 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.02%
|
6,199
|
$63,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,933
|
$30,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,662
|
$27,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,400
|
$25,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
855
|
$9,000 | — | 31 Mar 2018 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
453
|
$5,000 | — | 31 Mar 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q2 2018
As of 30 Jun 2018,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,723,565 shares.
The largest 10 holders included
FMR LLC, Artemis Investment Management LLP, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, Prudence Asset Management Ltd, Marshall Wace North America L.P., BlackRock Inc., and Dean Capital Investments Management, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
22
Q2 2018 holders
19
Holder diff
-3
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.